Former President Biden said the country is in the midst of “dark days” under President Trump. “Friends, I can’t sugar coat ...

Former President Joe Biden spoke publicly for the first time since completing a round of radiation therapy for an aggressive ...

The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

The former president spoke publicly for the first time since completing a round of radiation therapy for an aggressive form ...

Male breast and prostate cancer need equal awareness. Know symptoms, risks, and why early detection and regular screening are ...

Biotech insiders tout antibody-drug conjugates as the next big thing in cancer treatment, with firms urged to pursue global ...